Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martijn ten Berge is active.

Publication


Featured researches published by Martijn ten Berge.


Journal of Surgical Oncology | 2014

Safety of Elective Colorectal Cancer Surgery: Non-Surgical Complications and Colectomies are Targets for Quality Improvement

D. Henneman; Martijn ten Berge; H.S. Snijders; Nicoline J. van Leersum; Marta Fiocco; Theo Wiggers; Rob A. E. M. Tollenaar; Michel W.J.M. Wouters

Mortality following severe complications (failure‐to‐rescue, FTR) is targeted in surgical quality improvement projects. Rates may differ between colon‐ and rectal cancer resections.


The Annals of Thoracic Surgery | 2016

The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit

David Jonathan Heineman; Martijn ten Berge; Johannes Marlene Daniels; Michael I.M. Versteegh; Perla J. Marang-van de Mheen; M.W.J.M. Wouters; Wilhelmina Hendrika Schreurs

BACKGROUND Clinical staging of non-small cell lung cancer (NSCLC) determines the initial treatment offered to a patient. The similarity between clinical and pathologic staging in some studies is as low as 50%, and others publish results as high as 91%. The Dutch Lung Surgery Audit is a clinical database that registers the clinical and pathologic TNM of almost all NSCLC patients who undergo operations in the Netherlands. The objective of this study was to determine the accuracy of clinical staging of NSCLC. METHODS Prospective data were derived from the Dutch Lung Surgery Audit in 2013 and 2014. Patients were included if they had undergone a surgical resection for stage IA to IIIB NSCLC without neoadjuvant treatment and had a positron emission tomography-computed tomography scan as part of the clinical workup. Clinical (c)TNM and pathologic (p)TNM were compared, and whether discrepancy was based on tumor or nodal staging was determined. RESULTS From 2,834 patients identified, 2,336 (82.4%) fulfilled the inclusion criteria and had complete data. Of these 2,336, 1,276 (54.6%) were staged accurately, 707 (30.3%) were clinically understaged, and 353 (15.1%) were clinically overstaged. In the understaged group, 346 patients had a higher pN stage (14.8%), of which 148 patients had unforeseen N2 disease (6.3%). In the overstaged group, 133 patients had a cN that was higher than the pN (5.7%). CONCLUSIONS Accuracy of NSCLC staging in the Netherlands is low (54.6%), even in the era of positron emission tomography-computed tomography. Especially accurate nodal staging remains challenging. Future efforts should include the identification of specific pitfalls in NSCLC staging.


The Annals of Thoracic Surgery | 2018

Dutch Lung Surgery Audit: A National Audit Comprising Lung and Thoracic Surgery Patients

Martijn ten Berge; Naomi Beck; David Jonathan Heineman; Ronald Damhuis; Willem H. Steup; Pieter Jan van Huijstee; Jan Peter Eerenberg; Eelco J. Veen; Alexander P.W.M. Maat; Michel I.M. Versteegh; Thomas J van Brakel; Wilhemina Hendrika Schreurs; Michel W.J.M. Wouters

BACKGROUND The nationwide Dutch Lung Surgery Audit (DLSA) started in 2012 to monitor and evaluate the quality of lung operations in The Netherlands as an improvement tool. This outline describes the establishment, structure, and organization of the audit by the Dutch Society of Lung Surgeons (NVvL) and the Dutch Society of Cardiothoracic Surgeons (NVT), in collaboration with the Dutch Institute for Clinical Auditing. In addition, the first 4-year results are presented. METHODS The NVvL and NVT initiated a web-based registration, including weekly updated online feedback for participating hospitals. Data verification by external data managers is performed on regular basis. The audit is incorporated in national quality improvement programs, and participation in the DLSA is mandatory by health insurance organizations and the National Healthcare Inspectorate. RESULTS Between January 1, 2012, and December 31, 2015, all hospitals performing lung operations participated, and a total of 19,557 patients were registered from which almost half comprised lung cancer patients. Nationwide the guideline adherence increased over the years, and 96.5% of lung cancer patients were discussed in preoperative multidisciplinary teams. Overall postoperative complications and mortality after non-small cell lung cancer operations were 15.5% and 2.0%, respectively. CONCLUSIONS The audit provides reliable benchmarked information for caregivers and hospital management with potential to start local, regional, or national improvement initiatives. Currently, the audit is further completed with data from nonsurgical lung cancer patients, including treatment data from pulmonary oncologists and radiation oncologists. This will ultimately provide a comprehensive overview of lung cancer treatment in The Netherlands.


Journal of Surgical Oncology | 2014

Safety of elective colorectal cancer surgery: Non-surgical complications and colectomies are targets for quality improvement: Targets for Quality Improvement

D. Henneman; Martijn ten Berge; H.S. Snijders; Nicoline J. van Leersum; Marta Fiocco; Theo Wiggers; Rob A. E. M. Tollenaar; Michel W.J.M. Wouters

Mortality following severe complications (failure‐to‐rescue, FTR) is targeted in surgical quality improvement projects. Rates may differ between colon‐ and rectal cancer resections.


Journal of Surgical Oncology | 2014

Safety of elective colorectal cancer surgery

D. Henneman; Martijn ten Berge; H.S. Snijders; Nicoline J. van Leersum; Marta Fiocco; Theo Wiggers; Rob A. E. M. Tollenaar; Michel W.J.M. Wouters; Dutch Surgical Colorectal Audit Gr

Mortality following severe complications (failure‐to‐rescue, FTR) is targeted in surgical quality improvement projects. Rates may differ between colon‐ and rectal cancer resections.


The Annals of Thoracic Surgery | 2016

Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands—Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit

David Jonathan Heineman; Martijn ten Berge; Johannes Marlene Daniels; Michael I.M. Versteegh; Perla J. Marang-van de Mheen; M.W.J.M. Wouters; Wilhelmina Hendrika Schreurs


Lung Cancer | 2016

Peri- and postoperative management of stage I-III Non Small Cell Lung Cancer: Which quality of care indicators are evidence-based?

Rachel C. Numan; Martijn ten Berge; Jacobus A. Burgers; Houke M. Klomp; Johanna W. van Sandick; Paul Baas; Michel W.J.M. Wouters


Lung Cancer | 2016

Pre- and postoperative care for stage I–III NSCLC: Which quality of care indicators are evidence-based?

Rachel C. Numan; Martijn ten Berge; Jacobus A. Burgers; Houke M. Klomp; Johanna W. van Sandick; Paul Baas; Michel W.J.M. Wouters


Interactive Cardiovascular and Thoracic Surgery | 2015

P-245DISCREPANCY BETWEEN CLINICAL AND PATHOLOGICAL TNM STAGE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AND THE LONG-TERM SURVIVAL

Martijn ten Berge; David Jonathan Heineman; Wilhelmina Hendrika Schreurs; M.W.J.M. Wouters


Interactive Cardiovascular and Thoracic Surgery | 2014

P-212THE DUTCH LUNG SURGERY AUDIT

Martijn ten Berge; Willem H. Steup; P.H.J.M. Veldman; M.W.J.M. Wouters; Wilhelmina Hendrika Schreurs

Collaboration


Dive into the Martijn ten Berge's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

M.W.J.M. Wouters

Netherlands Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Henneman

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

H.S. Snijders

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicoline J. van Leersum

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Rob A. E. M. Tollenaar

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Theo Wiggers

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Houke M. Klomp

Netherlands Cancer Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge